This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sonogene LLC. Active years: 2015-2016.
Company Filing History:
Years Active: 2015-2016
Title: Eric Coles - Innovator in Sonochemical Induction
Introduction
Eric Coles is an accomplished inventor based in Glen Ellyn, IL (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene expression and cellular transfection. With a total of 2 patents to his name, Coles is recognized for his innovative approaches to enhancing HDL levels in the blood.
Latest Patents
Coles' latest patents focus on the sonochemical induction of ABCA1 expression. The first patent provides methods for transfecting liver cells to express ABCA1, which is crucial for increasing HDL levels. The invention includes compositions that consist of a pharmaceutically acceptable aqueous carrier containing sonochemically-active microspheres. These microspheres are designed to release encapsulated gas when exposed to ultrasonic acoustic energy. The second patent reiterates similar methodologies and compositions, emphasizing the use of gas bubbles encapsulated within protein or lipid shells to facilitate the transfection process.
Career Highlights
Eric Coles is currently associated with Sonogene LLC, where he continues to develop innovative solutions in biotechnology. His work has the potential to impact therapeutic strategies for cardiovascular health by improving HDL levels through advanced cellular techniques.
Collaborations
Coles collaborates with Michael H Davidson, a fellow innovator in the field. Their combined expertise enhances the research and development efforts at Sonogene LLC.
Conclusion
Eric Coles is a notable inventor whose work in sonochemical induction and gene expression is paving the way for advancements in biotechnology. His contributions are significant in the pursuit of improved health outcomes through innovative methods.